Skip to main content
. 2023 Sep 7;13:14779. doi: 10.1038/s41598-023-41971-z

Table 3.

The pooled mean and mean difference of clinical data in spondyloarthritis patients with and without uveitis of the included studies.

Subgroup Uveitis (+) Uveitis (–) Mean difference 95% CI p value (I2)
Pooled mean 95% CI Pooled mean 95% CI
Delay diagnosis (y) 6.08 4.77 to 7.38 5.41 3.94 to 6.89 1.04 0.28 to 1.80 0.008 (83%)
ASDAS 2.47 2.31 to 2.64 2.32 2.15 to 2.50 0.18 0.11 to 0.25  < 0.001 (0%)
BASDAI 4.87 4.41 to 5.32 4.53 4.11 to 4.96 0.11 − 0.06 to 0.28 0.21 (76%)
BASFI 3.89 3.53 to 4.25 3.97 3.65 to 4.28 − 0.12 − 0.46 to 0.21 0.47 (92%)
CRP (mg/L) 15.78 8.38 to 23.18 14.53 8.69 to 20.38 1.48 − 0.17 to 3.14 0.08 (64%)
ESR (mm/h) 28.19 7.64 to 48.75 28.16 17.91 to 38.42 − 0.80 − 4.62 to 3.03 0.68 (90%)
ASDAS-CRP 2.42 2.26 to 2.59 2.31 2.11 to 2.51 0.17 0.10 to 0.24  < 0.001 (0%)
ASDAS-ESR 2.76 2.47 to 3.05 2.37 2.26 to 2.48 0.03 − 0.65 to 0.72 0.92 (94%)
Subgroup BASDAI BASFI Study number
Pooled mean 95% CI Pooled mean 95% CI
 ≤ 2 years 4.46 4.32 to 4.61 2.92 2.48 to 3.37 1 (6)
 > 2 years, ≤ 5 years 5.60 5.47 to 5.73 3.98 3.67 to  4.28 2 (22, 23)
 > 5 years, ≤ 10 years 4.40 4.32 to 4.49 4.06 3.91 to 4.20 3 (15, 17, 19)
 > 10 years 3.74 2.63 to 4.85 4.17 2.93 to 5.41 1 (18)